EX-23.1 4 g084895_ex23-1.htm EX-23.1

Exhibit 23.1

 

 

INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM’S CONSENT

 

We consent to the incorporation by reference in this Registration Statement on Form S-8 of our report dated March 27, 2025 relating to the financial statements appearing in the Annual Report on Form 10-K of Pelthos Therapeutics Inc. (f/k/a Channel Therapeutics Corporation) for the year ended December 31, 2024.

 

/s/ Marcum llp

 

Hartford, CT

July 25, 2025